Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria.
暂无分享,去创建一个
T. Mukohara | M. Hirokawa | A. Miyauchi | Yasuhiro Ito | A. Miya | Toshihiko Kasahara | H. Minami | N. Kiyota | K. Nibu | N. Otsuki | Y. Imamura | H. Goto | M. Toyoda | N. Chayahara | Hirotaka Suto | Y. Nagatani